Trial site
The First Affiliated Hospital of Xi'an Medical University
- 12running trials
- 10closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Obesity9 trials
- Type 2 diabetes6 trials
- Alzheimer disease3 trials
- Asthma2 trials
- Stroke2 trials
- Chronic kidney disease1 trial
- Diabetic eye disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Heart failure1 trial
- Migraine1 trial
- Peripheral artery disease1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 318 trials
- Phase 21 trial
- Status
- Completed9 trials
- Recruiting8 trials
- Active, not recruiting2 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Boehringer Ingelheim5 trials
- Eli Lilly and Company5 trials
- Pfizer3 trials
- Hoffmann-La Roche2 trials
- Xijing Hospital2 trials
- and 5 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Enrolling by invitation
Recruiting
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Recruiting
Recruiting
Recruiting
Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases (ACT-AD)
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
Recruiting
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity3 recruiting
- Alzheimer disease2 recruiting
- Asthma1 recruiting
- Diabetic eye disease1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Peripheral artery disease1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Site data: ClinicalTrials.govUpdated 19 Nov 2026